Ubs Group Ag Reviva Pharmaceuticals Holdings, Inc. Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 223,541 shares of RVPH stock, worth $160,949. This represents 0.0% of its overall portfolio holdings.

Number of Shares

223,541

Holding current value

$160,949

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$0.95 - $2.08 $212,363 - $464,965	223,541 New	223,541 $212,000
Q3 2024 Nov 14, 2024	SELL	$0.64 - $1.48 $83,281 - $192,587	-130,127 Reduced 98.25%	2,313 $3,000
Q2 2024 Aug 13, 2024	BUY	$1.25 - $3.79 $155,426 - $471,252	124,341 Added 1535.26%	132,440 $169,000
Q1 2024 May 13, 2024	BUY	$2.76 - $5.52 $22,353 - $44,706	8,099 New	8,099 $30,000
Q1 2022 May 16, 2022	SELL	$1.61 - $3.01 $3,162 - $5,911	-1,964 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.23 $1,042 - $1,632	386 Added 24.46%	1,964 $6,000
Q3 2021 Nov 15, 2021	SELL	$3.29 - $4.79 $1,496 - $2,179	-455 Reduced 22.38%	1,578 $6,000
Q2 2021 Aug 13, 2021	BUY	$4.05 - $8.7 $8,233 - $17,687	2,033 New	2,033 $10,000
Q1 2021 May 12, 2021	SELL	$5.4 - $9.49 $9,234 - $16,227	-1,710 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$7.92 - $11.16 $13,543 - $19,083	1,710 New	1,710 $15,000

Others Institutions Holding RVPH

# of Institutions

Shares Held

7.42M

Call Options Held

938K

Put Options Held

62.1K

Vanguard Group Inc Valley Forge, PA

1.8M
Shares

$1.3 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.53M
Shares

$1.1 Million
0.0% of portfolio
Diadema Partners LP Morristown, NJ

651K
Shares

$468,520
0.16% of portfolio
Tang Capital Management LLC San Diego, CA

510K
Shares

$367,436
0.03% of portfolio
Geode Capital Management, LLC Boston, MA

419K
Shares

$301,780
0.0% of portfolio

View Full List

About REVIVA PHARMACEUTICALS HOLDINGS, INC.

Ticker RVPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,442,900
Market Cap $14.7M
Description
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...

More about RVPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account